Rare spinal tumor review describes frequent recurrence or progression
Published reports of spinal oligodendroglioma describe varied symptoms and treatment, with substantial recurrence or progression. These cases cannot establish which treatment approach works best.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This abstract-based review describes a rare spinal tumor using published individual cases and case series. Recurrence or progression was reported frequently, and surgery was the main treatment. The evidence helps describe how these tumors have presented and been managed, but it does not establish the best treatment or predict an individual patient's course.
The abstract does not give the denominator for recurrence or progression or explain how follow-up differed across cases. Case reports and case series do not provide a controlled comparison of treatments.
What researchers found
Reported tumor recurrence or progression
Descriptive rate across reviewed cases, with median follow-up of 28.5 months; no comparator was reported, and the outcome denominator was not specified.
What presentation looked like
Limb weakness, back pain and changes in sensation were among the presenting symptoms. MRI was the main diagnostic tool reported. These descriptions concern published tumor cases and cannot estimate risk among people with similar symptoms.
What treatment reports can show
Surgical removal was the most commonly reported treatment, and some patients also received additional therapy. Because this review summarized case reports and case series, the treatment patterns alone cannot show which approach produced better outcomes.
The original publication
Spinal oligodendroglioma: a > 70-year systematic review of current literature.
Balasubramanian K, Kharbat AF, Yurtluk MD et al.
J Neurosurg Spine · 2025
- PubMed ID
- 41172367
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.